Last Updated: November 8, 2026

Elite Labs Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ELITE LABS INC

ELITE LABS INC has nineteen approved drugs.

Summary for Elite Labs Inc

US Patents:	0
Tradenames:	14
Ingredients:	14
NDAs:	19

Drugs and US Patents for Elite Labs Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Elite Labs Inc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	209385-003	Jul 2, 2018	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
Elite Labs Inc	TRIMIPRAMINE MALEATE	trimipramine maleate	CAPSULE;ORAL	077361-001	Aug 2, 2006	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Elite Labs Inc	LOXAPINE SUCCINATE	loxapine succinate	CAPSULE;ORAL	076868-002	Aug 4, 2005	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Elite Labs Inc	HYDROCODONE BITARTRATE AND ACETAMINOPHEN	acetaminophen; hydrocodone bitartrate	TABLET;ORAL	209924-003	Nov 16, 2018	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
Elite Labs Inc	DANTROLENE SODIUM	dantrolene sodium	CAPSULE;ORAL	076686-001	Oct 24, 2005	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Elite Labs Inc	LISDEXAMFETAMINE DIMESYLATE	lisdexamfetamine dimesylate	CAPSULE;ORAL	218604-006	Nov 15, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Elite Labs Inc	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET, EXTENDED RELEASE;ORAL	217862-001	Nov 10, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.